Why does cancer rarely spread to the heart? Researchers develop organ-on-a-chip platform to find out

Researchers from the University of Toronto have created a new multi-organ-on-a-chip device to investigate why the heart is one of the least common sites of cancer metastasis, creating new opportunities for cancer research and drug discovery.

The heart’s unusual resistance to cancer has long puzzled scientists and may contain important clues for preventing metastasis in other organs. The new multi-organ-on-a-chip platform makes it possible to study this phenomenon in a controlled laboratory setting. Using the platform, the team found that aggressive breast cancer cells readily invaded engineered liver tissue but showed significantly reduced invasion into cardiac tissue.

The platform, called the Multi-organ Invasion Device (MInD), connects multiple engineered tissues within a single system under dynamic fluid flow. It allows researchers to observe how cancer cells move between tissue environments and how each organ influences their behavior. The research team published their findings in Nature Communications.

Sign up for Blog Updates